Lilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion - Bloomberg.com

Insilico Medicine Cayman TopCo’s shares jumped on Monday after it struck an artificial intelligence-driven drug development deal with Eli Lilly & Co. worth up to $2.75 billion.

You will be redirected in 10 seconds.